In severe alcohol-associated liver disease with limited documented abstinence, what prospectively measurable psychosocial signals are sufficient for you to support expedited listing (treatment engagement, insight, caregiver reliability, objective toxicology strategy), and which findings reliably predict unacceptable relapse risk in your experience?

1 Answers

Mednet Member

Hepatology · UC San Diego Health

I will give an answer that is a bit more subjective than objective. There are certainly validated scoring systems (Stanford Integrated Psychosocial Assessment for Transplantation [SIPAT], Sustained Alcohol Use Post-Liver Transplant [SALT]) that can help assess psychosocial risk in all patients, espe...